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Dear Editor,
A 63-year-old man underwent CT studies before surgery for
an aortic aneurysm. Contrast medium-enhanced CT scan
showed an increased spleen size with a solid, 10 cm large,
round, well-defined highly enhanced lesion, suggesting high
vascularity with nonhomogeneous density due to the pres-
ence of some pseudocystic areas (Fig. 1a) [1]. An increased
spleen size had been discovered 13 years before without any
symptoms and/or abnormality in complete blood counts
(CBCs). Three years later, MRI studies confirmed a slightly
increased lesion (12 cm) with a thin hypointense halo and a
heterogeneous hyperintense signal intensity on T2-weighted
images (i.e., well hydrated) (Fig. 1b, c). Diffusion-weighted
images showed patterns compatible with a high cellularity
(Fig. 1d). So, malignancy could not be excluded, and the
patient underwent splenectomy.
Histological examination was consistent with extramedullary
hematopoiesis, characterized by sinusoidal dilatation and
hypolobated megakaryocytes often gathered in clusters
(Fig. 1e, f). CBC and blood smears remained within the normal
range. However, bone marrow examination showed an in-
creased cellularity of 70 % with trilineage hyperplasia, with no
increased fibrosis or blasts. The search of JAK2V617Fmutation
was negative. Even if clinical and hematological findings did not
fulfill the WHO 2008 diagnostic criteria for any of the myelo-
proliferative neoplasms [2], histological pattern of the bone
marrow was suggestive for polycythemia vera, and hematopoi-
esis in the spleen had features resembling myelofibrosis. Two
years after splenectomy, evidence of a myeloproliferative neo-
plasm did not occur.
Extramedullary hematopoiesis can be a compensatory
response to hyperproliferating bone marrow cells, as is the
case of hemoglobinopathies such as thalassemia syndromes,
sickle-cell anemia, and other chronic hemolytic anemias, or
can occur in patients with chronic myeloproliferative neo-
plasms, especially myelofibrosis. Foci of extramedullary
hematopoiesis can be found in various organs, even if it
predominantly affects the liver and spleen. The localizations
of extramedullary hematopoiesis may be also in the thoracic
paravertebral areas, lymph nodes, adrenal gland, retroperi-
toneal fat, and renal pelvis [3, 4].
To our knowledge, only a few cases of focal
extramedullary hematopoiesis have been reported with
imaging descriptions [5]. In fact, spleen tumors are
usually detectable but not easily characterizable by
imaging due to overlapping patterns between benign
and malignant nodules. The greatest part of neoplasms
of the spleen is benign: hemangiomas, inflammatory
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pseudotumors, and splenic cysts are the most frequent
[6, 7], while lymphoma is the most common of ma-
lignancies, followed by other less frequent histologic
types as hemangioendotheliomas, hemangiosarcomas,
and metastases [8]. Our report emphasizes the role
of radiologic features for the diagnosis of intrasplenic
extramedullary hemopoiesis, bearing in mind that
splenic biopsy is a very risky procedure.
Even if none of the above-described findings is
neither sufficient nor necessary for definitive diagno-
sis, the association of well-defined lesion, highly and
inhomogeneously enhancing, with pseudocystic areas,
and medium-high signal intensity in MRI—T2 and
diffusion weighted—not resembling hemangioma or
pseudotumor, could suggest radiologists a diagnosis
of intrasplenic extramedullary hemopoiesis [4, 5] and
then clinicians to perform tests for hematological disorders
including myeloproliferative neoplasms, such as bonemarrow
biopsy, JAK2V617F of MPL mutations in addition to CBC,
before referring the patient for splenectomy which can bring
some risks of complications.
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Fig. 1 a CT scan after
administration of intravenous
contrast medium shows a large
focal lesion with well-defined
margin and heterogeneous density
due to internal colliquative areas.
b, cMRI, T2-weighted coronal
(b), and axial (c) scans confirm the
lesion with heterogeneous signal
intensity, slightly hyperintense on
T2-weighted images, with a thin
hypointense halo. dMRI and
heavily diffusion-weighted axial
scans show high signal intensity
and then a pattern suggestive for
crammed cells. e, f Histological
examination of the nodule,
showing extramedullary
hematopoiesis with ectasic
sinusoids and clustered
hypolobated megakaryocytes
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